We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HHS icon
2551
Harte-Hanks
HHS
$18.5M
$32K ﹤0.01%
2,975
NAVB
2552
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$29K ﹤0.01%
3,500
OCC icon
2553
Optical Cable Corp
OCC
$141M
$28K ﹤0.01%
12,869
NIHD
2554
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$15K ﹤0.01%
31,600
FTEK icon
2555
Fuel Tech
FTEK
$43.7M
$14K ﹤0.01%
13,700
BIOL
2556
DELISTED
Biolase, Inc.
BIOL
$11K ﹤0.01%
1
WAC
2557
DELISTED
Walter Investment Mgt Corp
WAC
$10K ﹤0.01%
16,168
BONT
2558
DELISTED
Bon-Ton Stores Inc/The
BONT
$6K ﹤0.01%
14,200
FPP.WS
2559
DELISTED
FieldPoint Petroleum Corporation Common Stock Purchase Warrants
FPP.WS
$2K ﹤0.01%
46,200
CYHHZ
2560
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
73,700
ACHV icon
2561
Achieve Life Sciences
ACHV
$695M
-21
Closed -$17K
AMC icon
2562
AMC Entertainment Holdings
AMC
$2.14B
-1,444
Closed -$328K
BAC.PRL icon
2563
Bank of America Series L
BAC.PRL
$4B
-161
Closed -$202K
CM icon
2564
Canadian Imperial Bank of Commerce
CM
$109B
-19,090
Closed -$775K
CRD.B icon
2565
Crawford & Co Class B
CRD.B
$585M
-107,452
Closed -$999K
EGO icon
2566
Eldorado Gold
EGO
$10.2B
-4,100
Closed -$54K
EWS icon
2567
iShares MSCI Singapore ETF
EWS
$1.17B
-8,600
Closed -$203K
FTK icon
2568
Flotek Industries
FTK
$1.41B
-57,616
Closed -$3.09M
HURN icon
2569
Huron Consulting
HURN
$2.43B
-227,765
Closed -$9.84M
MOMO
2570
Hello Group
MOMO
$861M
-536,404
Closed -$19.8M
NOAH
2571
Noah Holdings
NOAH
$591M
-50,255
Closed -$1.44M
NTRA icon
2572
Natera
NTRA
$45.1B
-103,875
Closed -$1.13M
RDY icon
2573
Dr. Reddy's Laboratories
RDY
$10.4B
-297,775
Closed -$2.51M
SGU icon
2574
Star Group
SGU
$415M
-86,594
Closed -$939K
SVM
2575
Silvercorp Metals
SVM
$2.79B
-873,050
Closed -$2.78M

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.